Guohua Yu Selected Research

quinolinium dibromide (QdB)

1/2023	ELISA-like QDB method to meet the emerging need of Her2 assessment for breast cancer patients.
1/2021	3D Visualization of the Dynamic Bidirectional Talk Between ER/PR and Her2 Pathways.
1/2020	Developing a routine lab test for absolute quantification of HER2 in FFPE breast cancer tissues using Quantitative Dot Blot (QDB) method.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guohua Yu Research Topics

Disease

34	Neoplasms (Cancer) 01/2024 - 01/2014
10	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2014
9	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2012
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 01/2015
5	Lymphoma (Lymphomas) 03/2023 - 01/2020
5	Disease Progression 01/2023 - 01/2021
5	Prion Diseases (Transmissible Spongiform Encephalopathies) 11/2021 - 04/2006
4	Carcinoma (Carcinomatosis) 11/2023 - 02/2011
4	Stomach Neoplasms (Stomach Cancer) 01/2023 - 01/2016
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 01/2020
4	Carcinogenesis 01/2022 - 11/2009
3	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 01/2019
3	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2023 - 09/2010
3	Adenocarcinoma of Lung 01/2023 - 01/2015
3	Infections 11/2021 - 12/2011
3	Heart Failure 09/2020 - 01/2018
3	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2020 - 03/2014
3	Alzheimer Disease (Alzheimer's Disease) 02/2020 - 09/2010
2	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 11/2017
2	Ischemic Stroke 01/2024 - 09/2010
2	Stroke (Strokes) 01/2024 - 03/2022
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2023 - 01/2021
2	Anemia 12/2023 - 11/2021
2	Fatigue 12/2023 - 03/2022
2	Consciousness Disorders 07/2023 - 10/2019
2	Adenocarcinoma 01/2023 - 01/2019
2	Cardiotoxicity 11/2022 - 01/2018
2	Lung Neoplasms (Lung Cancer) 01/2022 - 06/2016
2	Pleural Effusion (Pleural Effusions) 01/2022 - 09/2020
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 01/2021
2	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 07/2011
2	Scrapie 11/2021 - 04/2009
2	Gout 01/2021 - 01/2020
2	Inflammation (Inflammations) 01/2021 - 11/2018
2	T-Cell Lymphoma (Lymphoma, T Cell) 01/2020 - 01/2020
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2019 - 01/2019
2	Hypoxia (Hypoxemia) 11/2017 - 01/2016
2	Parkinson Disease (Parkinson's Disease) 09/2015 - 09/2010
1	Thyroid Neoplasms (Thyroid Cancer) 01/2024
1	Triple Negative Breast Neoplasms 01/2024
1	Lung Diseases (Lung Disease) 12/2023
1	Pneumonia (Pneumonitis) 12/2023
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2023
1	Pure Red-Cell Aplasia 12/2023

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2023 - 03/2014
5	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 03/2014
4	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2018
4	PrionsIBA 11/2021 - 04/2009
4	Prion ProteinsIBA 11/2021 - 04/2006
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2024 - 01/2012
3	Liposomes (Liposome)IBA 01/2024 - 01/2022
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2024 - 01/2022
3	LigandsIBA 01/2024 - 11/2020
3	human ERBB2 proteinIBA 11/2023 - 01/2021
3	ErbB Receptors (EGF Receptor)IBA 11/2023 - 01/2015
3	quinolinium dibromide (QdB)IBA 01/2023 - 01/2020
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 07/2015
3	Tyrosine Kinase InhibitorsIBA 01/2019 - 06/2016
3	Small Interfering RNA (siRNA)IBA 01/2019 - 01/2012
2	BerberineIBA 01/2024 - 01/2022
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2024 - 10/2022
2	AlbuminsIBA 01/2024 - 01/2018
2	monomethyl auristatin EIBA 11/2023 - 01/2021
2	Formaldehyde (Formol)FDA Link 01/2023 - 01/2021
2	ParaffinIBA 01/2023 - 01/2021
2	Gemcitabine FDA Link 11/2022 - 01/2022
2	Carboplatin (JM8)FDA LinkGeneric 11/2022 - 01/2022
2	B7-H1 AntigenIBA 10/2022 - 01/2021
2	Oncogene Proteins (Oncogene Protein)IBA 08/2022 - 01/2022
2	Etoposide (VP 16)FDA LinkGeneric 01/2022 - 03/2014
2	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2021
2	CurcuminIBA 01/2022 - 01/2018
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2021 - 01/2021
2	Estrogen ReceptorsIBA 01/2021 - 01/2019
2	Capsules (Microcapsules)IBA 01/2021 - 01/2017
2	Antineoplastic Agents (Antineoplastics)IBA 01/2018 - 01/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2017 - 01/2017
2	Transcription Factors (Transcription Factor)IBA 01/2016 - 03/2014
2	Eosine Yellowish-(YS) (Eosin)IBA 07/2011 - 02/2011
2	Hematoxylin (Haematoxylon)IBA 07/2011 - 02/2011
1	Glycyrrhetinic Acid (Po 12)IBA 01/2024
1	Monoclonal AntibodiesIBA 01/2024
1	Fluorouracil (Carac)FDA LinkGeneric 01/2024
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2024
1	toripalimabIBA 01/2024
1	Surface Antigens (Surface Antigen)IBA 01/2024
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2023
1	ibrutinibIBA 12/2023
1	Hemoglobins (Hemoglobin)IBA 12/2023
1	disitamab vedotinIBA 11/2023
1	Indicators and Reagents (Reagents)IBA 07/2023
1	CD19 AntigensIBA 03/2023
1	CytokinesIBA 03/2023

Therapy/Procedure

19	Therapeutics 01/2024 - 12/2016
11	Drug Therapy (Chemotherapy) 01/2024 - 01/2017
5	Immunotherapy 01/2024 - 01/2021
4	Transcranial Direct Current Stimulation 01/2023 - 10/2019
4	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021 - 11/2018
2	Radiotherapy 01/2020 - 02/2015
2	Aftercare (After-Treatment) 01/2020 - 01/2015